These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
618 related articles for article (PubMed ID: 27957604)
1. A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury. Thelin EP; Nelson DW; Bellander BM Acta Neurochir (Wien); 2017 Feb; 159(2):209-225. PubMed ID: 27957604 [TBL] [Abstract][Full Text] [Related]
2. Role of the S100B serum biomarker in the treatment of children suffering from mild traumatic brain injury. Filippidis AS; Papadopoulos DC; Kapsalaki EZ; Fountas KN Neurosurg Focus; 2010 Nov; 29(5):E2. PubMed ID: 21039136 [TBL] [Abstract][Full Text] [Related]
3. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point. Rainey T; Lesko M; Sacho R; Lecky F; Childs C Resuscitation; 2009 Mar; 80(3):341-5. PubMed ID: 19150161 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury. Park SH; Hwang SK World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306 [TBL] [Abstract][Full Text] [Related]
5. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. Pelinka LE; Kroepfl A; Leixnering M; Buchinger W; Raabe A; Redl H J Neurotrauma; 2004 Nov; 21(11):1553-61. PubMed ID: 15684648 [TBL] [Abstract][Full Text] [Related]
7. Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males. da Rocha AB; Schneider RF; de Freitas GR; André C; Grivicich I; Zanoni C; Fossá A; Gehrke JT; Pereira Jotz G; Kaufmann M; Simon D; Regner A Clin Chem Lab Med; 2006; 44(10):1234-42. PubMed ID: 17032136 [TBL] [Abstract][Full Text] [Related]
8. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage. Kellermann I; Kleindienst A; Hore N; Buchfelder M; Brandner S Clin Neurol Neurosurg; 2016 Jun; 145():79-83. PubMed ID: 27101088 [TBL] [Abstract][Full Text] [Related]
9. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Baker AJ; Rhind SG; Morrison LJ; Black S; Crnko NT; Shek PN; Rizoli SB J Neurotrauma; 2009 Aug; 26(8):1227-40. PubMed ID: 19637968 [TBL] [Abstract][Full Text] [Related]
10. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial. Hellewell SC; Conquest A; Little L; Vallance S; Board J; Bellomo R; Cooper DJ; Morganti-Kossmann MC J Clin Neurosci; 2020 Jun; 76():5-8. PubMed ID: 32331937 [TBL] [Abstract][Full Text] [Related]
11. Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h. Gonzćlez-Mao MC; Repáraz-Andrade A; Del Campo-Pérez V; Alvarez-García E; Vara-Perez C; Andrade-Olivié MA Clin Lab; 2011; 57(7-8):587-97. PubMed ID: 21888023 [TBL] [Abstract][Full Text] [Related]
12. S100B is not a reliable prognostic index in paediatric TBI. Piazza O; Storti MP; Cotena S; Stoppa F; Perrotta D; Esposito G; Pirozzi N; Tufano R Pediatr Neurosurg; 2007; 43(4):258-64. PubMed ID: 17627141 [TBL] [Abstract][Full Text] [Related]
13. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury? Sieber M; Dreßler J; Franke H; Pohlers D; Ondruschka B J Forensic Leg Med; 2018 Apr; 55():65-73. PubMed ID: 29471249 [TBL] [Abstract][Full Text] [Related]
14. Can serum biomarkers be used to rule out significant intracranial pathology in emergency department patients with mild traumatic brain injury? A Systemic Review & Meta-Analysis. Rogan A; O'Sullivan MB; Holley A; McQuade D; Larsen P Injury; 2022 Feb; 53(2):259-271. PubMed ID: 34763896 [TBL] [Abstract][Full Text] [Related]
15. Reliability of calcium-binding protein S100B measurement toward optimization of hyperosmolal therapy in traumatic brain injury. Hendoui N; Beigmohammadi MT; Mahmoodpoor A; Ahmadi A; Abdollahi M; Hasanpour M; Hadi F; Khazaeipour Z; Mousavi S; Mojtahedzadeh M Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):477-85. PubMed ID: 23467946 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury. Geyer C; Ulrich A; Gräfe G; Stach B; Till H J Neurosurg Pediatr; 2009 Oct; 4(4):339-44. PubMed ID: 19795965 [TBL] [Abstract][Full Text] [Related]
17. Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Shahim P; Gren M; Liman V; Andreasson U; Norgren N; Tegner Y; Mattsson N; Andreasen N; Öst M; Zetterberg H; Nellgård B; Blennow K Sci Rep; 2016 Nov; 6():36791. PubMed ID: 27819296 [TBL] [Abstract][Full Text] [Related]
18. Serum S100B concentrations are increased after closed head injury in children: a preliminary study. Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Kochanek PM J Neurotrauma; 2002 Nov; 19(11):1405-9. PubMed ID: 12490005 [TBL] [Abstract][Full Text] [Related]
19. S100B serum level predicts computed tomography findings after minor head injury. Müller K; Townend W; Biasca N; Undén J; Waterloo K; Romner B; Ingebrigtsen T J Trauma; 2007 Jun; 62(6):1452-6. PubMed ID: 17563665 [TBL] [Abstract][Full Text] [Related]
20. Functional resting-state fMRI connectivity correlates with serum levels of the S100B protein in the acute phase of traumatic brain injury. Thompson WH; Thelin EP; Lilja A; Bellander BM; Fransson P Neuroimage Clin; 2016; 12():1004-1012. PubMed ID: 27995066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]